Commentary: We still need observational studies of drugs - They just need to be better

International Journal of Epidemiology

Volumn 35, Issue 5, 2006, Pages 1310-1311

  Smeeth, Liam ^a   Douglas, Ian ^a   Hubbard, Richard ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACCURACY; ANTICHOLINERGIC SYNDROME; CASE STUDY; CONFOUNDING VARIABLE; CONFUSION; CONSCIOUSNESS DISORDER; DEPRESSION; DRUG CHOICE; DRUG MARKETING; DRUG WITHDRAWAL; EXPERIMENTAL STUDY; FALLING; FRACTURE; HIP FRACTURE; HUMAN; INJURY; MEDICAL DECISION MAKING; NOTE; OBSERVATIONAL STUDY; ORTHOSTATIC HYPOTENSION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS;

CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FRACTURES, BONE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RESEARCH DESIGN; RISK ASSESSMENT; SELECTION BIAS;

EID: 33750216647     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyl134     Document Type: Note

References (12)

1. Clarke A, Deeks JJ, Shakir SA. An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets. Drug Saf 2006;29:175-81.
2. Committee For Medicinal Products For Human Use. Guideline On Risk Management Systems For Medicinal Products For Human Use. London: European Medicines Agency, 2005.
3. The General Practice Research Database (GPRD). Available at: http://www.gprd.com/home/ (Accessed May 2006).
4. The Health Improvement Network (THIN). Available at: http://www.epic-uk.org/thin.htm (Accessed May 2006).
5. QRESEARCH. Available at: http://www.qresearch.org/ (Accessed May 2006).
6. Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med 1991;10:577-81.
7. Ray WA, Griffin MR, Malcolm E. Cyclic antidepressants and the risk of hip fracture. Arch Intern Med 1991;151:754-56.
8. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998;351:1303-07.
9. Hubbard R, Farrington CP, Smith C, Smeeth L, Tattersfield A. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 2003;158:77-84.
10. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995;51:228-35.
11. Whitaker HJ, Paddy FC, Spiessens B, Musonda P. Tutorial in biostatistics: The self-controlled case series method. Stat Med 2006;25:1768-97.
12. Evans S. Commentary: Matched cohorts can be useful. BMJ 2003;326:357.